Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women
- PMID:10837286
- DOI: 10.1093/ajcn/71.6.1462
Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women
Abstract
Background: Soy consumption is known to reduce plasma total cholesterol and LDL cholesterol in hypercholesterolemic subjects, but the responsible soy components and the effects in normocholesterolemic subjects remain unclear.
Objective: The effects of soy isoflavone consumption on plasma total cholesterol, HDL-cholesterol, LDL-cholesterol, triacylglycerol, apolipoprotein A-I, apolipoprotein B, and lipoprotein(a) concentrations and on LDL peak particle diameter were examined in normocholesterolemic, premenopausal women.
Design: Thirteen healthy, normocholesterolemic, free-living, premenopausal female volunteers took part in this randomized, crossover-controlled trial. Each subject acted as her own control. Three soy isoflavone intakes (control: 10.0 +/- 1.1; low: 64.7 +/- 9.4; and high: 128.7 +/- 15.7 mg/d), provided as soy protein isolate, were consumed for 3 menstrual cycles each. Total cholesterol, HDL cholesterol, LDL cholesterol, and triacylglycerol were measured over the menstrual cycle. Apolipoprotein A-I, apolipoprotein B, lipoprotein(a), and LDL peak particle diameter were evaluated in the midluteal phase.
Results: Total cholesterol, HDL-cholesterol, and LDL-cholesterol concentrations changed significantly across menstrual cycle phases (P < 0.005). During specific phases of the cycle, the high-isoflavone diet lowered LDL cholesterol by 7.6-10.0% (P < 0.05), the ratio of total cholesterol to HDL cholesterol by 10.2% (P < 0.005), and the ratio of LDL to HDL cholesterol by 13.8% (P < 0.002).
Conclusions: Isoflavones significantly improved the lipid profile across the menstrual cycle in normocholesterolemic, premenopausal women. Although of small magnitude, these effects could contribute to a lower risk of developing coronary heart disease in healthy people who consume soy over many years.
Similar articles
- Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women.Wangen KE, Duncan AM, Xu X, Kurzer MS.Wangen KE, et al.Am J Clin Nutr. 2001 Feb;73(2):225-31. doi: 10.1093/ajcn/73.2.225.Am J Clin Nutr. 2001.PMID:11157317Clinical Trial.
- Effect of soy protein varying in isoflavone content on serum lipids in healthy young men.McVeigh BL, Dillingham BL, Lampe JW, Duncan AM.McVeigh BL, et al.Am J Clin Nutr. 2006 Feb;83(2):244-51. doi: 10.1093/ajcn/83.2.244.Am J Clin Nutr. 2006.PMID:16469981Clinical Trial.
- Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials.Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S.Taku K, et al.Am J Clin Nutr. 2007 Apr;85(4):1148-56. doi: 10.1093/ajcn/85.4.1148.Am J Clin Nutr. 2007.PMID:17413118
- Role of isoflavones in the hypocholesterolemic effect of soy.Demonty I, Lamarche B, Jones PJ.Demonty I, et al.Nutr Rev. 2003 Jun;61(6 Pt 1):189-203. doi: 10.1301/nr.2003.jun.189-203.Nutr Rev. 2003.PMID:12903829Review.
- Hormonal effects of soy in premenopausal women and men.Kurzer MS.Kurzer MS.J Nutr. 2002 Mar;132(3):570S-573S. doi: 10.1093/jn/132.3.570S.J Nutr. 2002.PMID:11880595Review.
Cited by
- Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis.Sirtori CR.Sirtori CR.Drug Saf. 2001;24(9):665-82. doi: 10.2165/00002018-200124090-00003.Drug Saf. 2001.PMID:11522120Review.
- Design and optimization of a novel method for extraction of genistein.Pandit NT, Patravale VB.Pandit NT, et al.Indian J Pharm Sci. 2011 Mar;73(2):184-92. doi: 10.4103/0250-474x.91583.Indian J Pharm Sci. 2011.PMID:22303062Free PMC article.
- Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females.Carlson S, Peng N, Prasain JK, Wyss JM.Carlson S, et al.Gend Med. 2008;5 Suppl A(Suppl A):S76-90. doi: 10.1016/j.genm.2008.03.008.Gend Med. 2008.PMID:18395685Free PMC article.Review.
- Heterologous production of flavanones in Escherichia coli: potential for combinatorial biosynthesis of flavonoids in bacteria.Kaneko M, Hwang EI, Ohnishi Y, Horinouchi S.Kaneko M, et al.J Ind Microbiol Biotechnol. 2003 Aug;30(8):456-61. doi: 10.1007/s10295-003-0061-1. Epub 2003 May 21.J Ind Microbiol Biotechnol. 2003.PMID:12759810Review.
- Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis.Hooper L, Ryder JJ, Kurzer MS, Lampe JW, Messina MJ, Phipps WR, Cassidy A.Hooper L, et al.Hum Reprod Update. 2009 Jul-Aug;15(4):423-40. doi: 10.1093/humupd/dmp010. Epub 2009 Mar 19.Hum Reprod Update. 2009.PMID:19299447Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical